Introduction
T here is sparse literature regarding patients' ability to return to work following spinal surgery for axial low back pain (LBP). Specifically, the time frame for return to work, as well as factors associated with preoperative and postoperative employment, are unknown. The indirect costs associated with the postoperative recovery period for these interventions also have not been determined. With health care costs continuing to rise, economic considerations such as these are becoming increasingly important in decisions regarding treatment alternatives and the allocation of health care resources, 1 especially in the care of the patient with back pain.
The societal costs of back pain are dramatic. It has become the second most common reason for a visit to a primary care provider. Back pain is widely prevalent and afflicts 80% of the population 60 years of age and older. The percentage of patients with acute LBP who ultimately progress to chronic LBP has been estimated to be anywhere from 2% to 34%. 2 A small subset of these patient may benefit from operative intervention for back pain. In the workforce, lumbar back pain remains one of the greatest contributors to health-related loss of productivity. Previous estimates of health care expenditures for LBP in the United States have been conservatively estimated to be in excess of $90 billion per year. 3 Chronic LBP, defined as longer than 3 months of symptoms, is generally regarded as having a poorer prognosis than acute back pain. 4 The sum of the literature suggests that surgery for axial lumbar back pain can have successful outcomes for carefully selected patients. A variety of procedures aimed at alleviating chronic LBP without radiculopathy have been utilized. In the setting of single-level degenerative disc disease, the most common surgical treatment is fusion of the involved spinal segments, though results are inconsistent. 5 Due to technological advancements, a recent alternative is total disc replacement surgery, though long-term data regarding efficacy are limited. 6 Unfortunately, these recent advancements in spine surgery have seen the introduction of newer, more costly implants and procedures. The soaring costs of spinal implants and biologic adjuncts to fusion have resulted in increased scrutiny of the clinical and economic impact of these interventions.
Costs related to an operative intervention can be divided into direct costs (ie, costs associated with direct medical treatment including surgery and postoperative monitoring) and indirect costs (ie, costs associated with lost productivity due to illness). Direct costs typically are viewed from either a provider (hospital and=or physician) or payer (insurer) perspective. From the provider perspective, direct costs include costs related to the hospitalization including facility costs, therapy costs, costs of diagnostic testing, and medical device costs. Additional direct medical costs from the provider perspective include the cost of the surgeon's time. From the payer perspective, direct costs include facility and physician costs related to the hospitalization as well as costs related to follow-up care and the management of postoperative complications.
In contrast, indirect costs are more difficult to determine and relate to lost workforce productivity resulting from absence at work (absenteeism) or decreased productivity at work (presenteeism). Numerous studies have cited multiple factors associated with return to work following an episode of LBP that was treated nonoperatively. [7] [8] [9] To our knowledge, the time frame for return to work and factors associated with preoperative and postoperative employment status following surgery for LBP have not been previously described, nor has an estimate of the indirect costs related to these procedures been previously published.
Recently, clinical trial data have become available from a prospective multicenter study that compared the safety and effectiveness of the Charité artificial lumbar disc to anterior lumbar interbody fusion (ALIF) using threaded cages with iliac crest bone graft (ICBG) for the treatment of single-level degenerative disc disease at L4-L5 or L5-S1. Guyer and colleagues 10 analyzed this data comparing the direct costs of the 2 procedures used in the clinical trial from both hospital and payer perspectives. They found the overall economic effect of 1-level total disc replacement on hospitals and payers to be roughly equivalent to 1-level fusion.
From the provider=hospital perspective, the cost of operative intervention was $16,600 for the Charité artificial disc and $18,600 for ALIF with ICBG. From a payer perspective, direct costs were examined from 2 different points of view, a Diagnosis Related Group (DRG) payment arm and a per diem payment arm. The hospital costs from a DRG payment arm perspective were $17,600 for the Charité artificial disc and $33,000 for ALIF with ICBG. Costs from a per diem payment arm perspective were $24,900 for the Charité artificial disc and $23,800 for ALIF with ICBG, though for consistency these figures were based on 100% reimbursement of spinal implant costs across all comparators in the study. Regardless, the direct costs related to operative treatment of single-level degenerative disc disease are significant.
In an effort to add to this discussion regarding the economics of operative intervention for LBP, we analyzed the clinical trial data comparing the Charité artificial disc and ALIF with ICBG procedures to estimate the time frame for and factors associated with return to work and to estimate the indirect costs of surgery for LBP due to absenteeism.
Methods
We prospectively reviewed the clinical data from a noninferiority trial of 304 patients randomized in a 2:1 ratio to receive either the Charité artificial disc replacement (205 patients) or ALIF with ICBG (99 patients). Inclusion and exclusion criteria for this study were strict in an effort to include only those patients with back pain, leg pain, or both (but without radiculopathy) secondary to single-level degenerative disc disease at L4-L5 or L5-S1, while minimizing potentially confounding variables. 11 These criteria have been published previously.
Data included results of the Visual Analog Scale (VAS) for pain, the Oswestry Disability Index (ODI), and the Short Form (SF)-36 health survey recorded preoperatively, postoperatively, at 6 weeks, and at 3, 6, 12, and 24 months after surgery. The employment status of enrolled subjects was categorized at these same time intervals as: full time, part time, long-term disability leave, short-term disability leave, unemployed, retired, and other (none of the above).
In order to better understand patient characteristics predicting return to work, a logistic regression model was constructed. Several variables were screened for inclusion in the model including sex, age, body mass index (BMI), treatment received, baseline employment, normal activity level, pain medication use, baseline and 24-month postoperative ODI score, baseline and 24-month postoperative VAS score, and baseline and 24-month postoperative SF-36 score. The variables were pared down using hierarchical elimination. The final model included sex, age, treatment, baseline employment, and 24-month postoperative ODI and SF-36 Physical and Mental Health Composite scores. The adequacy of this model was verified using the Hosmer Lemeshow goodness-of-fit test.
Indirect costs related to absenteeism were estimated by determining the level of productivity at each follow-up. In order to better understand the economic impact of these changes in productivity, the estimated earnings for patients who underwent each procedure were calculated at each follow-up. The average weekly salary for both treatment groups was calculated using age-adjusted weekly salaries based on national averages from the US Bureau of Labor Statistics. These salaries were prorated for those who worked part time. The average weekly salary was then calculated overall and for both treatment groups at each follow-up. Indirect costs related to absenteeism were estimated as the wages lost as a result of absence from work.
Aggregate data was provided by Depuy Spine (DePuy Spine, Inc., Raynham, MA). Institutional Review Board approval was received for this study. Data were analyzed using Microsoft Excel 2002 (Microsoft Corporation, Redmond, WA) and SPSS v16.0 statistical software package (SPSS Inc., Chicago, IL).
Results
Patient demographics for the study population are presented in Table 1 . The average age of enrolled subjects was 39.6 years. The majority were white (>85%), and most subjects were physically active (>85%). There were some minor differences between groups with fusion patients having a slightly higher degree of obesity, slightly more female subjects, and slightly more minority patients. The overall mean preoperative ODI, VAS, and SF-36 scores were equivalent between groups (Table 2 ) and reflected significant disability.
We determined the number of subjects who worked full or part time prior to surgery as a percentage of the entire study population and also as a percentage of the study population on payroll (ie, currently working or receiving employer paid short-term and long-term disability). The percentage of the entire study population who worked full or part time prior 10 FAYSSOUX ET AL.
to surgery averaged 55% overall (53% for the Charité group and 57% for the fusion group). The percentage of subjects on payroll averaged 75% (75% for the Charité group and 77% for the fusion group).
As would be expected, immediately after surgery there was a substantial decrease in the number of subjects who worked full or part time. However, at 6 weeks postoperatively, the percentage of the entire study population who were working full or part time averaged 24% overall (26% for the Charité group and 24% for the fusion group). The percentage of subjects on payroll who were working full or part time averaged 40% (41% for the Charité group and 37% for the fusion group). There was a gradual increase over the 2-year follow-up period (Fig. 1) . Stratification to include only those subjects on payroll prior to surgery showed the Charité group tended to have a slightly higher percentage working at each follow-up. Using a linear regression model, return to baseline preoperative employment levels occurred approximately 6 months postoperatively for the entire study population and for workers on payroll in both groups. At 24 months, the percentage of the entire study population who were employed full or part time had increased 16% (ie, from 54.3% to 63.2%) when compared to the baseline preoperative Logistic regression analysis showed, not surprisingly, that being employed at baseline was a strong predictor of return to work; however, other baseline characteristics such as BMI, pain medication use, or function as measured by ODI or SF-36 were not significant independent predictors. Recovery at 24 months, as measured by ODI and SF-36 Mental Component Summary (MCS) score, also was shown to be closely associated with return to work (Table 3) .
In order to better understand the economic impact of the changes in productivity, the estimated earnings for patients who underwent each procedure were calculated at each follow-up using US Bureau of Labor Statistics data (Fig. 1) . The average weekly salary for full-time workers was estimated to be $728 overall, $725 for the Charité group, and $735 for the fusion group. In general, weekly salaries were greater in the Charité group than the fusion group at each follow-up, despite the lower estimated earning potential in the Charité group. Lost productivity related to absenteeism for this study population resulted in costs to society averaging $2884 per patient in the first year following surgery.
Discussion
We analyzed prospectively collected data from a multicenter trial that compared Charité with fusion in order to establish the time frame for return to work and factors associated with preoperative and postoperative employment status, and to estimate the indirect costs of surgery for LBP related to absenteeism. We found only 75% of subjects on payroll (ie, currently working or receiving employer paid short-or long-term disability) were working full or part time prior to surgery. A significant drop occurred in the percentage of patients reporting full-or part-time employment 6 weeks after surgery, with a gradual increase over the following 2 years. Return to preoperative productivity levels occurred between 6 and 12 months postoperatively. Two years postoperatively the employment status had increased approximately 16%. Given the delay in return to productivity related to absenteeism, the short-term indirect costs from a societal perspective are substantial; however, the higher employment status at 2 years suggests a long-term benefit. Further research in this regard is needed.
The low preoperative employment rate of patients is not surprising given that nearly 80% of patients had preoperative ODIs of 40% or greater, values associated with severe disability. The delay in return to preoperative productivity levels likely resulted from the postoperative rehabilitation associated with anterior lumbar spine surgery. The relatively lower success rate of operative treatment of isolated axial back pain certainly played a role as well. This delay in productivity resulted in significant costs in the short term. 
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Logistic regression analysis showed that, of the limited number of candidate predictive variables that were available for this analysis, few were predictive of return to work. Baseline employment status, improvement in functional status as measured by the ODI, and improvement in MCS on the SF-36 were associated with return to work. While this finding is largely intuitive, it does suggest that postsurgical interventions, such as physical and occupational therapy, may hasten return to work, although clearly this conclusion is speculative.
The indirect costs related to absenteeism of surgery for LBP in this study population were $2,884 per patient during the first postoperative year. The majority of these indirect costs were related to absenteeism in the first several postoperative months as employment rates reached baseline at approximately 6 months postoperatively. Currently, data regarding indirect costs of spinal surgery are lacking. As economic considerations become an increasingly important issue, cost effectiveness evaluations will find increasing importance in the surgical literature of the spine. This article adds to the literature a rough measure of the indirect costs associated with spine surgery for LBP.
This article has several limitations. The full analysis of indirect costs requires consideration of costs related to presenteeism. Unfortunately, there were no data to allow for this determination. Additionally, the criteria for inclusion into the clinical trial were fairly strict in an effort to include only subjects with single-level degenerative disc disease without radiculopathy, while limiting confounding factors. These strict criteria may have resulted in an overestimation of indirect costs because subjects in this clinical trial had relatively severe disease. Finally, because actual salary data were not collected in the clinical trial, the estimation of average weekly salaries was based on age-adjusted data from the US Bureau of Labor Statistics. Therefore, the information on lost productivity costs presented here is a crude estimate; however, the findings do demonstrate the importance of including productivity measures in cost-effectiveness evaluations of LBP interventions.
In conclusion, a significant drop in employment follows surgery for axial LBP with either procedure; this may persist for close to 1 year postoperatively. By 2 years post surgery, employment rates increased to levels that exceeded those prior to surgery. Return to work after surgery may be predicted by preoperative employment status and ODI and SF-36 MCS outcomes at 24-months follow-up. The indirect costs related to absenteeism as a result of surgery for LBP are substantial, averaging just over $2800 per patient during the first postoperative year with the majority of the loss incurred in the first several months following surgery. These findings demonstrate the significant, though not surprising, impact of spinal disability on productivity, and the importance of including the measurement of lost productivity and return to work in the effectiveness and costeffectiveness evaluation of operative (and nonoperative) interventions.
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